Inovio Pharmaceuticals
INO
#9777
Rank
S$0.10 B
Marketcap
S$1.32
Share price
-3.77%
Change (1 day)
-33.86%
Change (1 year)

Inovio Pharmaceuticals (INO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$56.46 Million

According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are S$56.46 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$64.46 M6.12%
2024-12-31S$60.75 M-14.19%
2023-12-31S$70.79 M-58.15%
2022-12-31S$0.16 B29.96%
2021-12-31S$0.13 B25.12%
2020-12-31S$0.10 B-44.31%
2019-12-31S$0.18 B210.17%
2018-12-31S$60.22 M0.61%
2017-12-31S$59.85 M-17.83%
2016-12-31S$72.84 M35.84%
2015-12-31S$53.62 M100.43%
2014-12-31S$26.75 M-40.32%
2013-12-31S$44.83 M256.57%
2012-12-31S$12.57 M-26.7%
2011-12-31S$17.15 M48.51%
2010-12-31S$11.54 M-57.69%
2009-12-31S$27.29 M-3.99%
2008-12-31S$28.43 M126.06%
2007-12-31S$12.57 M-34.11%
2006-12-31S$19.08 M108.12%
2005-12-31S$9.17 M4.07%
2004-12-31S$8.81 M339.08%
2003-12-31S$2 M-31.71%
2002-12-31S$2.93 M-4.96%
2001-12-31S$3.09 M
2001-03-31S$2.89 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$154.65 B 273,773.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$102.84 B 182,023.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$151.43 B 268,067.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$42.43 B 75,048.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$106.91 B 189,228.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$77.75 B 137,597.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
S$2.15 B 3,719.21%๐Ÿ‡บ๐Ÿ‡ธ USA